Army witholds anitdote for chemical terror attack
WASHINGTON (AP) - Despite the interest of emergency officials, the government is refusing to provide U.S. communities an antidote controlled by the Army and stockpiled by other countries to treat victims of a chemical terror attack. The product, Reactive Skin Decontamination Lotion, was developed by the Canadian military years ago, won Food and Drug Administration approval in 2003 and is sold in other NATO countries for neutralizing sarin, mustard gas and other chemical agents.
It is being tested by the Army. But the companies that make it arenât permitted to sell it or even advertise it to state and local governments in the United States. "Right now they have no product to decontaminate people other than soap and water," said Phil OâDell, president of OâDell Engineering, a Canadian-based company licensed by the Canadian government to sell the lotion. "There is only one FDA-approved. Itâs the RSDL. These first responders correctly have been trying to buy RSDL since FDA approval."
Dr. Dani Zavasky, a deputy medical director for the New York Police Departmentâs counterterrorism bureau, thinks the antidote is promising and wonders why her agency cannot buy it. As described by the FDA at the time it approved it for the Army in April 2003, a lotion-soaked sponge is packaged in a special foil pouch that people can carry, ready to rip open and wipe on any exposed skin as soon as possible after exposure to a chemical attack. Zavasky said she heard about the antidote from Marines, not from the Army or the Homeland Security Department, whose duties include tipping off state and local governments to new anti-terrorism technologies. "Iâm not aware of any substance other than this out there that has been used for so long by others that has this benefit," Zavasky said. "Iâve been hearing about it for a year and a half now and still itâs not widely available."
The Army says it wants to do more testing on issues such as whether the lotion is safe to use with bleach, before it making it standard issue for its troops or letting police, firefighters and other first responders buy it. "The manufacturer will have to be patient. Until the compatibility with bleach solutions is determined and can be clearly defined, we canât field it," said Maj. Gary Tallman, an Army spokesman. "It wouldnât be proper to field it to our war fighters and our first responders."
In the United States, the Army rather than OâDell Engineering obtained the FDAâs approval, meaning OâDell cannot sell it to state and local governments without Army permission. But that doesnât preclude other federal agencies from trying to bring the drug to first responders. Homeland Security Department spokesman Kirk Whitworth said the agency doesnât comment on specific products but is "committed as a department to speeding the access to the most effective products available."
Frustrated by the delay, OâDell Engineering and its U.S. business partner, New York state-based E-Z-EM Inc., have started lobbying lawmakers and the Army.
Posted by: Mark Espinola 2004-06-14 |